Abstract: A unit pixel and a displaying apparatus including the unit pixel are provided. The unit pixel includes a transparent substrate, a plurality of light emitting devices arranged on the transparent substrate, a light blocking layer disposed between the transparent substrate and the light emitting devices, and having at least one window, and a semi-transmissive layer disposed between at least one of the plurality of light emitting devices and the transparent substrate to overlap with the window at least partially.

Abstract: Provided are novel fused-heterocyclyl-carbonohydrazonoyl dicyanide compounds and uses thereof.

Abstract: Provided are novel carbonohydrazonoyl dicyanide compounds including two or more aryl or heteroaryl groups connected via a linker and uses thereof.

Abstract: Provided are novel oxopyridazinyl-phenyl-carbonohydrazonoyl dicyanide compounds and uses thereof.

Abstract: Provided is a composition for injection containing isolated mitochondria. More specifically, provided is a liquid composition for injection containing glycine, saccharide, buffer, and mitochondria, and a pharmaceutical composition comprising the liquid composition for injection as an active ingredient. The liquid composition for injection according to the present disclosure is capable of securing the safety of a mitochondrial therapeutic and maintaining the activity of mitochondria, by enhancing the stability of mitochondria for prevention or treatment of mitochondria-related diseases and preventing and inhibiting formation of blood clots in the blood of a subject who is administered with the same.

Abstract: The present invention relates to novel hydrazone derivatives in which a terminal amine group is substituted with an aryl group or a heteroaryl group, and uses thereof.

Abstract: The present invention relates to a pharmaceutical composition for preventing or treating myositis. More particularly, the present invention relates to a pharmaceutical composition for preventing or treating myositis, comprising mitochondria as an active ingredient. When the pharmaceutical composition of the present invention comprising exogenous mitochondria as an active ingredient is administered to a subject suffering from myositis, inflammatory cells infiltrated into the muscle cells of the subject can be reduced. In addition, the pharmaceutical composition of the present invention effectively inhibits the expression of IL-1?, TNF-?, and IL-6, inflammatory cytokines. Therefore, the pharmaceutical composition according to the present invention can be usefully used for preventing or treating myositis.

Abstract: The present invention relates to a pharmaceutical composition for the treatment of sepsis or systemic inflammatory response syndrome (SIRS) comprising mitochondria as effective ingredient. When activated macrophages and monocytes are treated with mitochondria which are effective ingredient of the pharmaceutical composition of the present invention, expression of IL-1?, TNF-? and IL-6 which are pro-inflammatory cytokines can be restored to normal levels. Furthermore, when the pharmaceutical composition of the present invention is administered to a subject suffering from sepsis, the survival rate of the subject can be remarkably increased. Therefore, the pharmaceutical composition according to the present invention can be useful for the treatment of sepsis.

Abstract: A wireless power relaying device and a display system that distributes power wirelessly. A wireless power relaying device includes a relay coil producing a second magnetic field by a current induced from a first magnetic field produced from a first external device, and a magnetic body on which the relay coil is arranged. The magnetic body includes first, second, and third magnetic bodies arranged at a same distance from each other. A direction in which the relay coil is wound around the first magnetic body is different from a direction in which the relay coil is wound around the second and third magnetic bodies. The direction in which the relay coil is wound around the second coil is the same as the direction in which the relay coil is wound around the third coil. A power signal is sent to a second external device through the second magnetic field.

Abstract: The present invention relates to a pharmaceutical composition comprising (S)-2-(((4?-trifluoromethylbiphenyl-4-yl)methyl)amino)propanamide methanesulfonate or a pharmaceutically acceptable salt thereof as an effective ingredient for prevention or treatment of stroke.

Abstract: A display device includes: a display panel including a plurality of pixels; a data driver configured to supply a black voltage to the display panel; and a controller configured to: set an initial driving power voltage of the display panel; decide a bright spot voltage of the display panel while the data driver is supplying the black voltage to the display panel; and set any one of the bright spot voltage and the initial driving power voltage as a final driving power voltage.

Abstract: Provided is a wireless power transceiver including a magnetic body, a solenoid coil wound with respect to the magnetic body, and a dual coil spaced downwardly from the solenoid coil and wound with respect to the magnetic body on opposite sides of the solenoid coil, the dual coil being wound in directions opposite to each other.

Abstract: The present invention relates to a novel halo-(3-(phenylsulfonyl)prop-1-enyl)pyridine derivative or a pharmaceutically acceptable salt thereof; a preparation method thereof; and an Nrf2 activator and a pharmaceutical composition for preventing or treating diseases induced by a decrease in Nrf2 activity, both of which comprise the same as an active ingredient.

Abstract: The present invention relates to an electronic apparatus and display apparatus, and method for driving the apparatuses, and the display apparatus according to an embodiment of the present invention may comprise: a resonance circuit unit for generating voltage by means of inductive electromotive force generated due to an external apparatus; a rectification unit for rectifying the output voltage of the resonance circuit unit; and a converter for outputting the rectified voltage of the rectification unit as the target voltage by varying duty on the basis of duty data and target voltage determined in accordance with the distance from the external apparatus.

Abstract: The present invention relates to a display apparatus and operational method therefor, and an electronic apparatus, and the display apparatus according to an embodiment of the present invention may comprise: a resonance circuit unit for generating voltage by means of inductive electromotive force generated due to an external apparatus; a capacitance variance unit for varying the capacitance (Cv) of the resonance circuit unit in order to control the resonance point thereof, the resonance point having been changed due to the distance from the external apparatus; and a display panel for implementing an image by means of the voltage.

Abstract: The present invention relates to a pharmaceutical composition comprising (S)-2-(((4?-trifluoromethylbiphenyl-4-yl)methyl)amino)propanamide methanesulfonate or a pharmaceutically acceptable salt thereof as an effective ingredient for prevention or treatment of spinal cord injury.

Abstract: Described herein are compounds of Formulae (I)-(II), and pharmaceutically acceptable salts, and pharmaceutical compositions thereof. Also provided are methods and kits involving the inventive compounds or compositions for treating or preventing proliferative diseases such as cancers (e.g., lung cancer, large bowel cancer, pancreas cancer, biliary tract cancer, or endometrial cancer), benign neoplasms, angiogenesis, inflammatory diseases, autoinflammatory diseases, and autoimmune diseases in a subject.

Abstract: A wireless power relaying device and a display system that distributes power wirelessly. A wireless power relaying device includes a relay coil producing a second magnetic field by a current induced from a first magnetic field produced from a first external device, and a magnetic body on which the relay coil is arranged. The magnetic body includes first, second, and third magnetic bodies arranged at a same distance from each other. A direction in which the relay coil is wound around the first magnetic body is different from a direction in which the relay coil is wound around the second and third magnetic bodies. The direction in which the relay coil is wound around the second coil is the same as the direction in which the relay coil is wound around the third coil. A power signal is sent to a second external device through the second magnetic field.

Abstract: Provided is a wireless power transceiver including a magnetic body, a solenoid coil wound with respect to the magnetic body, and a dual coil spaced downwardly from the solenoid coil and wound with respect to the magnetic body on opposite sides of the solenoid coil, the dual coil being wound in directions opposite to each other.

Abstract: Provided are bifunctional small molecules of Formula (I): or pharmaceutically acceptable salts thereof, wherein M represents a small organic molecule which binds, covalently or non-covalently, a kinase, such as Her3 protein kinase; L1 represents a linker; and RH represents a hydrophobic group. An example of a compound of Formula (I) is a compound of Formula (II): Also provided are pharmaceutical compositions comprising a compound of Formula (I) or (II) and methods of using such compounds for treating proliferative diseases.